Filing Details

Accession Number:
0001437749-18-020647
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-11-13 20:12:22
Reporting Period:
2018-11-12
Accepted Time:
2018-11-13 20:12:22
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
925741 Biocardia Inc. BCDA Biological Products, (No Disgnostic Substances) (2836) 232753988
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1647542 Peter Altman C/O Biocardia, Inc.
125 Shoreway Road, Suite B
San Carlos CA 94070
President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-11-12 1,100 $2.35 720,592 No 4 P Direct
Common Stock Acquisiton 2018-11-13 2,800 $2.08 723,392 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
Footnotes
  1. This transaction was executed in multiple trades at prices ranging from $2.30 to $2.39 per share. The price reported above reflects the weighted average per share purchase price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer full information regarding the number of shares purchased at each separate price.
  2. This transaction was executed in multiple trades at prices ranging from $2.05 to $2.10 per share. The price reported above reflects the weighted average per share purchase price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer full information regarding the number of shares purchased at each separate price.